ChIP analysis shows that SLC1A5 binding site 1 is significantly enriched in YY1 antibody (Figure 4b and c), suggesting that YY1 can interact with SLC1A5 promoter binding site 1 in GBM cells. This evidence concerns the gene SLC1A5 and glioblastoma.